maximum androgen ablation

maximum androgen ablation

A form of hormonal therapy for prostate cancer using combined therapy—e.g., gonadotropin-releasing hormone agonist plus flutamide—to decrease effects of gonadal and adrenal androgens.
MAA was said to provide a ± 6 month survival advantage, but it is no longer in active use.

maximum androgen ablation

A form of hormonal therapy for prostate CA using combined therapy–eg, gonadotropin-releasing hormone agonist plus flutamide, to ↓ effects of gonadal and adrenal androgens